A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of oravescent fentanyl citrate for management of breakthrough pain in opioid-tolerant patients with chronic low back pain
Phase of Trial: Phase III
Latest Information Update: 25 Jun 2014
At a glance
- Drugs Fentanyl (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Cephalon
- 22 Sep 2006 The expected completion date for this trial is now .
- 19 Nov 2005 New trial record.